Sipp Industries Inc. (SIPC)
OTC PINK OTC PINK Primary 
SIPP Industries Announces Milestone Achievements in Partnership with Calypso Pharmaceuticals
COSTA MESA, CA / ACCESSWIRE / August 1, 2024 / SIPP Industries, Inc. (OTC PINK:SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products within the cannabis industry, proudly announces successful distribution and production milestones in collaboration with its partner, Calypso Pharmaceuticals. SIPP Industries and Calypso Pharmaceuticals have gained significant momentum within the Texas Hemp Industry by securing multiple key distributors and high-volume, multi-location retail storefronts in Dallas and Fort Worth.
SIPP Industries Announces Quarterly Plans and Projections
COSTA MESA, CA / ACCESSWIRE / July 18, 2024 / SIPP Industries (OTC PINK:SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products within the cannabis industry, is excited to announce its ambitious quarterly plans and projections, featuring significant advancements from its partner, Calypso Pharmaceuticals. Calypso Pharmaceuticals and SIPP Industries have been working diligently on AVEINA Melanoma topical, a groundbreaking formulation utilizing 1000mg of Nano Emulsified CBD and Peptide P16 to actively reduce cellular growth for all Melanoma cells.
SIPP Industries Appoints Adam Graziano as New CEO to Lead Next Chapter of Growth and Innovation
Costa Mesa, CA, June 25, 2024 – SIPP Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce the appointment of Adam Graziano as the new Chief Executive Officer, effective immediately.
SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma
Costa Mesa, CA, June 11, 2024 – SIPP Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce a Research and Development agreement with Calypso Pharmaceuticals.
